GGrantIndex
Sort

53,477 grants matching addiction

Genetic Targeting Core

$373,005
Edita Navratilova · University Of Arizona · P30 · FY2024 · DA

Genetic Targeting Core

$373,005
Edita Navratilova · University Of Arizona · P30 · FY2022 · DA

In Vivo Detection of Neuronal Activity

$372,934
Russell E Jacobs · California Institute Of Technology · R01 · FY2007 · DA

Psychology Training Alcohol Research

$372,928
Mary E Larimer · University Of Washington · T32 · FY2012 · AA

Development of PET radioligands for cerebral cannabinoid receptor (CB1)

$372,923
Andrew G Horti · Johns Hopkins University · R33 · FY2010 · MH

Understanding Pain Expression in Wabanaki People during Recovery: Enhancing Wabanaki Research, Data Self-Determination, and Capacity Development

$372,921
Selena Neptune-Bear · Wabanaki Health And Wellness · OT2 · FY2025 · DA

Drugs of Abuse & Synaptic Processes In Dopamine Systems

$372,912
Robert C Malenka · Stanford University · R01 · FY2007 · DA

Development of Drugs Acting at Ion Channels

$372,908
Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK

Astrocyte Calcium Signaling in Chronic Pain.

$372,880
Jeremy Thomas Smyth · Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2025 · NS

Orexin (hypocretin) signaling in ventral tegmental area as a common mediator of sleep disturbances and drug demand in cocaine abstinence

$372,867
Gary S. Aston-Jones · Rutgers Biomedical And Health Sciences · R01 · FY2024 · DA

Orexin (hypocretin) signaling in ventral tegmental area as a common mediator of sleep disturbances and drug demand in cocaine abstinence

$372,867
Gary S. Aston-Jones · Rutgers Biomedical And Health Sciences · R01 · FY2025 · DA

HIV/Drug Abuse Prevention Research Ethics Training Institute

$372,865
Celia B Fisher · Fordham University · R25 · FY2018 · DA

Microarray analysis of morphine's behavioral effects

$372,850
University Of Maryland Baltimore · R01 · FY2004 · DA

Cholinergic interneuron D2 receptor function in impulsive behavior: implications for addiction

$372,834
Eduardo Francisco Gallo · Fordham University · R01 · FY2022 · DA

Adenosine Receptor Involvement in Methamphetamine Reward and Relapse

$372,831
Ryan K. Bachtell · University Of Colorado · R01 · FY2016 · DA

Evaluating New Nicotine Standards for Cigarettes - Project 3

$372,824
Suzanne M Colby · Wake Forest University Health Sciences · U54 · FY2020 · DA

Perfusion fMRI in Cocaine Addiction

$372,818
University Of Pennsylvania · R01 · FY2002 · DA

The mechanisms driving brain oncogenesis by FGFR-TACC gene fusions

$372,815
Antonio Iavarone · Columbia University Health Sciences · R01 · FY2015 · CA

Dopamine Partial Agonists and Psychostimulant Dependence

$372,800
George F Koob · Scripps Research Institute, The · R01 · FY2007 · DA

RESEARCH EDUCATION PROGRAM ON COMPUTATIONAL AND STATISTICAL TOOL DEVELOPMENT FOR ADDICTION GENETICS

$372,786
Pamela Ann Madden · Washington University · R25 · FY2019 · DA

Molecular mechanisms of dense-core vesicle release

$372,769
Matthew R. Banghart · University Of California, San Diego · R35 · FY2020 · GM

Molecular mechanisms of dense-core vesicle release

$372,769
Matthew R. Banghart · University Of California, San Diego · R35 · FY2019 · GM

A Framework for Understanding Mechanisms of Policy Change: The Opioid Policy Taxonomy

$372,744
Rosanna Smart · Rand Corporation · P50 · FY2025 · DA

RNA methylation as a modulator of cancer genome instability

$372,739
Philipp Oberdoerffer · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Perfusion fMRI in Cocaine Addiction

$372,711
University Of Pennsylvania · R01 · FY2003 · DA